179 related articles for article (PubMed ID: 21272753)
1. Genetic warfarin dosing: tables versus algorithms.
Finkelman BS; Gage BF; Johnson JA; Brensinger CM; Kimmel SE
J Am Coll Cardiol; 2011 Feb; 57(5):612-8. PubMed ID: 21272753
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort.
Shin J; Kayser SR
Pharmacotherapy; 2011 Sep; 31(9):863-70. PubMed ID: 21923587
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance of warfarin pharmacogenetic algorithms in Chinese patients.
Liu Y; Yang J; Xu Q; Xu B; Gao L; Zhang Y; Zhang Y; Wang H; Lu C; Zhao Y; Yin T
Thromb Res; 2012 Sep; 130(3):435-40. PubMed ID: 22374335
[TBL] [Abstract][Full Text] [Related]
4. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
[TBL] [Abstract][Full Text] [Related]
5. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
[TBL] [Abstract][Full Text] [Related]
6. Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing.
Roper N; Storer B; Bona R; Fang M
J Mol Diagn; 2010 May; 12(3):283-91. PubMed ID: 20228265
[TBL] [Abstract][Full Text] [Related]
7. Integration of genetic, clinical, and INR data to refine warfarin dosing.
Lenzini P; Wadelius M; Kimmel S; Anderson JL; Jorgensen AL; Pirmohamed M; Caldwell MD; Limdi N; Burmester JK; Dowd MB; Angchaisuksiri P; Bass AR; Chen J; Eriksson N; Rane A; Lindh JD; Carlquist JF; Horne BD; Grice G; Milligan PE; Eby C; Shin J; Kim H; Kurnik D; Stein CM; McMillin G; Pendleton RC; Berg RL; Deloukas P; Gage BF
Clin Pharmacol Ther; 2010 May; 87(5):572-8. PubMed ID: 20375999
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
[TBL] [Abstract][Full Text] [Related]
9. Validation of warfarin pharmacogenetic algorithms in clinical practice.
Marin-Leblanc M; Perreault S; Bahroun I; Lapointe M; Mongrain I; Provost S; Turgeon J; Talajic M; Brugada R; Phillips M; Tardif JC; Dubé MP
Pharmacogenomics; 2012 Jan; 13(1):21-9. PubMed ID: 22176621
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups.
Dietz N; Ruff C; Giugliano RP; Mercuri MF; Antman EM
Int J Cardiol; 2020 Oct; 317():159-166. PubMed ID: 32505370
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic Warfarin Dosing Algorithms: Validity in Egyptian Patients.
Selim TE; Azzam HA; Ghoneim HR; Mohamed AA; El Wakeel H; Abu Bakr HM
Acta Haematol; 2018; 139(4):255-262. PubMed ID: 29996126
[TBL] [Abstract][Full Text] [Related]
12. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
13. International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events.
Karaca S; Bozkurt NC; Cesuroglu T; Karaca M; Bozkurt M; Eskioglu E; Polimanti R
Pharmacogenomics; 2015; 16(10):1109-18. PubMed ID: 26216670
[TBL] [Abstract][Full Text] [Related]
14. Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort.
Shin J; Cao D
Pharmacogenomics; 2011 Jan; 12(1):125-34. PubMed ID: 21174627
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic-guided Warfarin Dosing Algorithm in African-Americans.
Alzubiedi S; Saleh MI
J Cardiovasc Pharmacol; 2016 Jan; 67(1):86-92. PubMed ID: 26355760
[TBL] [Abstract][Full Text] [Related]
16. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
Cho SM; Lee KY; Choi JR; Lee KA
Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
[TBL] [Abstract][Full Text] [Related]
17. Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.
Lenzini PA; Grice GR; Milligan PE; Dowd MB; Subherwal S; Deych E; Eby CS; King CR; Porche-Sorbet RM; Murphy CV; Marchand R; Millican EA; Barrack RL; Clohisy JC; Kronquist K; Gatchel SK; Gage BF
J Thromb Haemost; 2008 Oct; 6(10):1655-62. PubMed ID: 18662264
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database.
Liu R; Li X; Zhang W; Zhou HH
PLoS One; 2015; 10(8):e0135784. PubMed ID: 26305568
[TBL] [Abstract][Full Text] [Related]
19. Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.
Sagreiya H; Berube C; Wen A; Ramakrishnan R; Mir A; Hamilton A; Altman RB
Pharmacogenet Genomics; 2010 Jul; 20(7):407-13. PubMed ID: 20442691
[TBL] [Abstract][Full Text] [Related]
20. Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.
Voora D; Eby C; Linder MW; Milligan PE; Bukaveckas BL; McLeod HL; Maloney W; Clohisy J; Burnett RS; Grosso L; Gatchel SK; Gage BF
Thromb Haemost; 2005 Apr; 93(4):700-5. PubMed ID: 15841315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
